These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11329135)

  • 1. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease.
    Wong BS; Green AJ; Li R; Xie Z; Pan T; Liu T; Chen SG; Gambetti P; Sy MS
    J Pathol; 2001 May; 194(1):9-14. PubMed ID: 11329135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.
    Meyne F; Gloeckner SF; Ciesielczyk B; Heinemann U; Krasnianski A; Meissner B; Zerr I
    J Alzheimers Dis; 2009; 17(4):863-73. PubMed ID: 19542614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's diseases?
    Weller RO
    J Pathol; 2001 May; 194(1):1-3. PubMed ID: 11329133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
    Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
    JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages.
    Shiga Y; Wakabayashi H; Miyazawa K; Kido H; Itoyama Y
    J Clin Neurosci; 2006 Jul; 13(6):661-5. PubMed ID: 16815706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Righetti PG; Ferrari S; Terrin L; Farinazzo A; Cardone F; Pocchiari M; Rizzuto N; Monaco S
    Electrophoresis; 2002 Jan; 23(2):347-55. PubMed ID: 11840543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.
    Herzog C; Rivière J; Lescoutra-Etchegaray N; Charbonnier A; Leblanc V; Salès N; Deslys JP; Lasmézas CI
    J Virol; 2005 Nov; 79(22):14339-45. PubMed ID: 16254368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry.
    Fagge T; Barclay GR; Macgregor I; Head M; Ironside J; Turner M
    Transfusion; 2005 Apr; 45(4):504-13. PubMed ID: 15819670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].
    Dervaux A; Vicart S; Lopes F; Le Borgne MH
    Encephale; 2001; 27(2):194-7. PubMed ID: 11407273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
    Blennow K; Lind B; Andersson E; Andreasen N
    Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
    Nailon WH; Ironside JW
    Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Stoeck K; Bodemer M; Ciesielczyk B; Meissner B; Bartl M; Heinemann U; Zerr I
    Arch Neurol; 2005 Oct; 62(10):1591-4. PubMed ID: 16216944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H; Gatterbauer B; Radbauer C; Budka H
    Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
    Minaki H; Sasaki K; Honda H; Iwaki T
    Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
    Ritchie DL; Head MW; Ironside JW
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prion diseases, update].
    Kitamoto T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1223-5. PubMed ID: 12235843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.
    Polymenidou M; Stoeck K; Glatzel M; Vey M; Bellon A; Aguzzi A
    Lancet Neurol; 2005 Dec; 4(12):805-14. PubMed ID: 16297838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BSE and vCJD cause disturbance to uric acid levels.
    Lekishvili T; Sassoon J; Thompsett AR; Green A; Ironside JW; Brown DR
    Exp Neurol; 2004 Nov; 190(1):233-44. PubMed ID: 15473996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.